MedPage Today August 3, 2023
Joyce Frieden

— All measures would require more transparency about the fees they collect

Confused by all the bills being introduced in Congress to regulate pharmacy benefit managers (PBMs)? You’re not alone.

Not only is the Senate Finance Committee working on legislation to regulate the PBMs — the “middlemen” between health insurers and patients who negotiate with drug companies to determine how much insurers and patients will pay for prescription pharmaceuticals — but so are at least four other congressional committees.

Here is a roundup of some of the bills, including which committees are working on them, what they would do, and what experts are saying about them:

House Education and Workforce Committee. This bill, called the Hidden Fee Disclosure Act, would...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
If enhanced ACA subsidies expire, 4M could become uninsured: report
MTT #89: Trump’s second term, weight-loss drugs & the rise of ‘walking pneumonia’
Looking to history to prepare for America’s uncertain future
Trump transition closes in on picks for top health posts
What will happen in healthcare following the election? Hear from our experts.

Share This Article